GGrantIndex
Sort

23,748 grants matching melanoma

Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer

$222,911
Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2016 · CA

Discrete Sensor Devices for Determining Cancer Targets

$222,774
Michael J Cima · Massachusetts Institute Of Technology · U54 · FY2012 · CA

UV Photodamage to the Skin: Prevention by Mutant p53 Immunization

$222,750
Craig A Elmets · University Of Alabama At Birmingham · R21 · FY2022 · ES

A tyrosinase-targeted drug design for the treatment of melanoma

$222,750
Majid Y Moridani · Texas Tech University Health Scis Center · R15 · FY2007 · CA

Quercitrin functions as an antioxidant and protects UV-induced carcinogenesis

$222,750
Zhuo Zhang · University Of Kentucky · R21 · FY2011 · ES

Cancer and Leukemia Group B

$222,743
Duke University · U10 · FY2004 · CA

Molecular Predictive Testing in Ocular Melanoma

$222,737
James W Harbour · Washington University · R01 · FY2006 · CA

Avirulent CD8+ T-cell Evading Oncolytic HSV-1 for the Treatment of Bladder Cancer

$222,694
Matthew Charles Mulvey · Benevir Biopharm, Inc. · R43 · FY2012 · CA

Biostatistics and Bioinformatics Core

$222,690
David P Harrington · Brigham And Women'S Hospital · P50 · FY2011 · CA

Diagnosis of Clinically Early Melanomas

$222,688
Meenhard Herlyn · Wistar Institute · P50 · FY2006 · CA

Dissecting drug resistance in serial uveal melanoma biopsies using integrated, multi-modal single-cell profiling and novel machine learning tools.

$222,661
Benjamin Izar · Columbia University Health Sciences · R21 · FY2022 · CA

VERMONT INBRE: LEAD INSTITUTION CORE

$222,615
Judith L Van Houten · University Of Vermont & St Agric College · P20 · FY2007 · RR

PEPTIDE VACCINES WITH/WITHOUT GMCSF IN STAGE IV MELANOMA

$222,525
University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA

Total Synthesis of Bioactive Compounds

$222,515
Andrew J Phillips · University Of Colorado · R01 · FY2007 · CA

Total Synthesis of Bioactive Compounds

$222,515
Andrew J Phillips · University Of Colorado · R01 · FY2008 · CA

Core C - Melanoma Screening and Stratification

$222,486
David F Stern · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2018 · CA

Core C - Melanoma Screening and Stratification

$222,486
David F Stern · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · CA

Autoimmune vitiligo as a roadmap to melanoma therapy

$222,472
Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2007 · CA

Regulation of Chemokine Mediated Leukocyte Functions

$222,470
Micheler Ricardo Richardson · North Carolina Central University · R01 · FY2006 · AI

ANTI-NEOPLASTIC EFFECTS OF GAMMA-SECRETASE INHIBITORS

$222,457
Lucio Miele · University Of Massachusetts Amherst · P01 · FY2008 · AG

Characterization of IL36, a novel cytokine

$222,390
Albert Zlotnik · University Of California-Irvine · R21 · FY2011 · AI

Targeting RAS in Pediatric Cancer

$222,334
Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Protease Activity in 3D Matrices

$222,224
Kristi S. Anseth · University Of Colorado · R21 · FY2015 · EB

Core B - Metabolomics

$222,200
Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2018 · CA

Core B - Metabolomics

$222,200
Andrei L Osterman · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · CA